(Q36765133)

16 August 2017

title

Human immunopathogenesis of severe acute respiratory syndrome (SARS). (English)

1 reference

16 August 2017

0 references

1

Mark J Cameron

1 reference

16 August 2017

author name string

Jesus F Bermejo-Martin

2

1 reference

16 August 2017

Ali Danesh

3

1 reference

16 August 2017

Matthew P Muller

4

1 reference

16 August 2017

David J Kelvin

5

1 reference

16 August 2017

publication date

19 March 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

133

1 reference

16 August 2017

issue

1

1 reference

16 August 2017

page(s)

13-19

1 reference

Radiographic-clinical correlation in severe acute respiratory syndrome: study of 1373 patients in Hong Kong.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Gene expression profiling of host response in models of acute HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Coordinate induction of IFN-alpha and -gamma by SARS-CoV also in the absence of virus replication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Severe Acute Respiratory Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Critically ill patients with severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

An interferon-gamma-related cytokine storm in SARS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Pulmonary pathology of severe acute respiratory syndrome in Toronto.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Pathogenesis of severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

A major outbreak of severe acute respiratory syndrome in Hong Kong

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Molecular signature of clinical severity in recovering patients with severe acute respiratory syndrome coronavirus (SARS-CoV).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Induction and regulation of IFNs during viral infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Early diagnosis of SARS: lessons from the Toronto SARS outbreak

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Lung pathology of fatal severe acute respiratory syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Evaluation of WHO criteria for identifying patients with severe acute respiratory syndrome out of hospital: prospective observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

ARDS in SARS: cytokine mediators and treatment implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Interferon signalling network in innate defence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Thin-section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Gene expression profiles in peripheral blood mononuclear cells of SARS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Severe acute respiratory syndrome coronavirus fails to activate cytokine-mediated innate immune responses in cultured human monocyte-derived dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

Preventing local transmission of SARS: lessons from Singapore.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.02.014

inferred from DOI database lookup

7 January 2021

based on heuristic

Functional classification of interferon-stimulated genes identified using microarrays

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17374415

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

SARS: systematic review of treatment effects

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17374415

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.VIRUSRES.2007.02.014

1 reference

16 August 2017

1 reference